ARTICLE AD BOX
A cancer vaccine developed by Merck and Moderna treating patients with melanoma showed positive and promising late-stage testing results. Moderna, Merck say cancer vaccine trial marks ‘landmark moment’
2 days ago
10
A cancer vaccine developed by Merck and Moderna treating patients with melanoma showed positive and promising late-stage testing results. 
English (US) ·